Introduction: The City of Whittlesea was selected as one of six LGAs for the Victorian Department of Health’s Social Prescribing Trial, in response to high rates of mental health challenges, addiction, and suicide. The Whittlesea Mental Health & Wellbeing Local embedded a Community Link program, staffed by a Social Prescribing Lead and three Link Workers, to address social isolation and disconnection through a holistic, community-based approach. This presentation explores how social prescribing was implemented and its impact on individuals and systems. Method: Link Workers collaborated with clinicians and peer workers to identify individuals experiencing isolation or disengagement. Through co-designed wellbeing plans, guests were supported to reconnect with interests, overcome barriers (e.g. transport, finances), and access community activities. The program operated on three levels: individual support, peer group facilitation, and cross-sector collaboration which included establishing a social-connection network for local services. Internal advocacy was required to embed social prescribing within clinical practice, with uptake increasing over time. Results: Guests engaged in diverse activities including art, nature-based programs, parenting supports, and men’s health initiatives. The program reached over 100 internal referrals, with participants reporting improved wellbeing, confidence, and social connection. However, limited service cohesion and siloed operations within the LGA posed challenges to implementation and sustainability. Discussion: The trial highlighted the importance of relational support, lived experience, and practical navigation in making social prescribing meaningful. It also revealed systemic barriers, including fragmented services and the need for cultural shifts within mental health practice. Significance: Social prescribing has been a lifeline for many, especially men, migrants, seniors, and trauma survivors. It fostered hope, purpose, and community belonging. Recommendations: A longer-term trial (minimum four years) is essential to embed social prescribing into multidisciplinary care, strengthen service cohesion, and sustain outcomes for individuals requiring extended support.